|
A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer
RECRUITINGPhase 1Sponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
PhasePhase 1
SponsorMemorial Sloan Kettering Cancer Center
Started2026-10-20
Est. completion2028-10-20
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations8 sites
View on ClinicalTrials.gov →
NCT07899892
Summary
The purpose of this study is to find out whether it is practical (feasible) to use a new type of imaging scan called 68Ga-FAPI PET/MRI (positron emission tomography/magnetic resonance imaging) to evaluate how well breast cancer responds to neoadjuvant chemotherapy.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥ 18 * ECOG Performance Status of ≤ 2 * Ability to review and signed informed consent * Histologically confirmed, newly diagnosed invasive breast cancer * Lymph node metastases (either histologically confirmed or radiographic evidence of lymph node metastases). * Planned to undergo SOC NAC prior to surgical resection as outlined in section 4.1 Exclusion Criteria: * Pregnancy or lactation. * Patients who cannot undergo PET/MRI scanning because of: * devices or implants that are not MRI safe * hypersensitivity or known allergy to gadolinium-based contrast agents * physical fitness not allowing scanning in prone for 30 minutes * weight limits (450 lb. weight limit) * Severe kidney disfunction (estimated GFR \< 30 ml/min/1.73 m2) (CKD-EPI (2021)) * Imaging features suspicious for concomitant in-situ cancer (LCIS/DCIS), such as nonbiopsied groups of microcalcifications * Distant metastases (contraindication for NAC)
Conditions3
Breast CancerCancerInvasive Breast Cancer
Locations8 sites
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Somali Gavane, MD212-639-2403
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Somali Gavane, MD212-639-2403
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Somali Gavane, MD212-639-2403
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity)
Simone Gavane, MD212-639-2403
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activity)
Somali Gavane, MD212-639-2403
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 1
SponsorMemorial Sloan Kettering Cancer Center
Started2026-10-20
Est. completion2028-10-20
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations8 sites
View on ClinicalTrials.gov →
NCT07899892